Provided by Tiger Trade Technology Pte. Ltd.

Corcept Therapeutics

112.00
+1.181.06%
Volume:184.86K
Turnover:20.70M
Market Cap:12.11B
PE:246.88
High:113.60
Open:110.82
Low:110.82
Close:110.82
52wk High:126.38
52wk Low:28.66
Shares:108.10M
Float Shares:96.44M
Volume Ratio:0.23
T/O Rate:0.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.4537
EPS(LYR):0.8200
ROE:8.23%
ROA:0.47%
PB:17.15
PE(LYR):136.59

Loading ...

Dec 31, 2025

Major Issues Report

Form 8-K - Current report
Dec 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 25, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 04, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2025

Major Issues Report

Form 8-K - Current report
Nov 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 14, 2025

Major Issues Report

Form 8-K - Current report
Oct 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 06, 2025

Major Issues Report

Form 8-K - Current report
Oct 02, 2025

Correspondence

Form CORRESP - Correspondence
Oct 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities